Exact Mass: 587.1387

Exact Mass Matches: 587.1387

Found 47 metabolites which its exact mass value is equals to given mass value 587.1387, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Benzenemethanol, 4-(1-(3,4-bis(difluoromethoxy)phenyl)-2-(3-methyl-1-oxido-4-pyridinyl)ethyl)-alpha,alpha-bis(trifluoromethyl)-

4-{2-[3,4-bis(difluoromethoxy)phenyl]-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]ethyl}-3-methylpyridin-1-ium-1-olate

C25H19F10NO4 (587.1154)

(S)-3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)benzamido)propanoic acid

3-[(4-{1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)formamido]propanoic acid

C32H27Cl2N3O4 (587.1379)

Quinoline, 6-(1-methyl-1-(methylsulfonyl)ethyl)-8-(3-((1E)-2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)ethenyl)phenyl)-

C31H29N3O5S2 (587.1549)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Tradipitant (VLY-686) is a neurokinin-1 (NK-1) antagonist.

Phosphoramidon disodium salt

C23H32N3Na2O10P (587.1621)

MK 0893

(S)-3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)benzamido)propanoic acid

C32H27Cl2N3O4 (587.1379)

6-(1-METHANESULFONYL-1-METHYL-ETHYL)-8-(3-[(E)-2-(4-METHANESULFONYL-PHENYL)-2-(3-METHYL-[1,2,4]OXADIAZOL-5-YL)-VINYL]-PHENYL)-QUINOLINE

C31H29N3O5S2 (587.1549)

Inarigivir

C20H26N7O10PS (587.1199)

Vestipitant Mesylate

C24H28F7N3O4S (587.1689)

C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent

3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-YL)-1H-pyrazol-1-YL)ethyl)benzamido)propanoic acid

C32H27Cl2N3O4 (587.1379)

(Z)-8-(3-(2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)vinyl)phenyl)-6-(2-(methylsulfonyl)propan-2-yl)quinoline

C31H29N3O5S2 (587.1549)

dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose(2-)

C18H27N3O15P2-2 (587.0917)

dTDP-beta-L-evernitrose

C18H27N3O15P2-2 (587.0917)

dTDP-4-acetamido-4,6-dideoxy-alpha-D-glucose(2-)

C18H27N3O15P2-2 (587.0917)

dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose(2-)

C18H27N3O15P2-2 (587.0917)

dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose

C18H27N3O15P2-2 (587.0917)

GDP-4-amino-4,6-dideoxy-alpha-D-mannose(1-)

C16H25N6O14P2- (587.0904)

1-[2-[3-Carboxylato-5-[[3-carboxylato-3-(2-carboxylato-2-hydroxy-5-oxopyrrolidin-1-yl)propyl]amino]-3-hydroxy-5-oxopentanoyl]oxyethyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate

C22H25N3O16-4 (587.1235)

GDP-mycosamine

C16H25N6O14P2- (587.0904)

dTDP-alpha-D-rubranitrose

C18H27N3O15P2-2 (587.0917)

dTDP-4-acetamido-4,6-dideoxy-D-galactose

C18H27N3O15P2-2 (587.0917)

1-[1-carboxylato-3-({(3R)-3-carboxylato-5-[2-(2-carboxylato-2-hydroxy-5-oxopyrrolidin-1-yl)ethoxy]-3-hydroxy-5-oxopentanoyl}amino)propyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate

C22H25N3O16-4 (587.1235)

dTDP-4-acetamido-4,6-dideoxy-D-glucose(2-)

C18H27N3O15P2-2 (587.0917)

Guanylyl-3,5-cytidine(1-)

C19H24N8O12P- (587.1251)

Phosphoramidon (Disodium)

C23H32N3Na2O10P (587.1621)

Phosphoramidon Disodium, a microbial metabolite, is a specific metalloprotease thermolysin inhibitor with an IC50 of 0.4 μg/mL. Phosphoramidon Disodium also inhibits endothelin-converting enzyme (ECE), neutral endopeptidase (NEP), and angiotensin-converting enzyme (ACE) with IC50 values of 3.5, 0.034, and 78 μM, respectively[1][2][3].

(2's,3's,4r)-2'-(6-bromo-1h-indol-3-yl)-2''-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2,5,5''-trione

C28H26BrN7O3 (587.128)

(2's,3's,4r)-2'-(6-bromo-1h-indol-3-yl)-2-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2'',5,5''-trione

C28H26BrN7O3 (587.128)

17,18-dichloro-1,4,7,11-tetrahydroxy-3-(1-hydroxyethyl)-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

C24H31Cl2N5O8 (587.155)

methyl (2r,7r,8s)-8-bromo-4-hydroxy-7-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-2h,3h,7h,8h,9h-pyrrolo[3,2-f]quinoline-2-carboxylate

C26H26BrN3O8 (587.0903)

methyl (2r,8s)-8-(bromomethyl)-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h-pyrrolo[3,2-e]indole-2-carboxylate

C26H26BrN3O8 (587.0903)

4-{[(5s)-8-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,5-dihydroxy-3-methyl-7,12-dioxo-5h-6-azatetraphen-6-yl]methyl}benzoic acid

C32H29NO10 (587.1791)

(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-1,4,7,11-tetrahydroxy-3-[(1r)-1-hydroxyethyl]-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-1,4,7,11-tetrahydroxy-3-[(1r)-1-hydroxyethyl]-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

C24H31Cl2N5O8 (587.155)

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-1-hexadecanoyl-3-hydroxypyrrolidin-2-one

C26H39Br2NO4 (587.1246)

2'-(6-bromo-1h-indol-3-yl)-2''-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2,5,5''-trione

C28H26BrN7O3 (587.128)

3-(3,4-dibromo-5-hydroxyphenyl)-1-hexadecanoyl-3-hydroxypyrrolidin-2-one

C26H39Br2NO4 (587.1246)

2'-(6-bromo-1h-indol-3-yl)-2-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2'',5,5''-trione

C28H26BrN7O3 (587.128)

methyl (2r,8s)-8-bromo-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h,9h-pyrrolo[3,2-f]quinoline-2-carboxylate

C26H26BrN3O8 (587.0903)